Together, our findings support a model in which SOX10 loss promotes a shift toward a drug-tolerant melanoma cell state characterized by increased reliance on TEAD-driven transcription and sensitivity to TEAD inhibition, indicating a context-dependent vulnerability. Here, SOX10 is linked to melanoma.